solifenacin
UkraineDrugs containing this active substance
-
The drug is indicated for the treatment of men with symptoms of benign prostatic hyperplasia. It helps with frequent or urgent urges to urinate, as well as difficulties with the bladder emptying process itself.
Form: tablets, modified release
Active substance Dosage solifenacin 4.5 mg tamsulosin 0.37 mg ATC: G04CA53
Manufacturer: Adamed Pharma S.A. (manufacturing, primary and secondary packaging, batch control and batch release)
-
The drug is used for the symptomatic treatment of urinary frequency, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 5 mg ATC: G04BD08
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 10 mg ATC: G04BD08
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is intended for the treatment of men with symptoms of benign prostatic hyperplasia. It helps with frequent or urgent urges to urinate and also improves the bladder emptying process.
Form: tablets, modified release
Active substance Dosage solifenacin 6 mg tamsulosin 0.4 mg ATC: G04CA53
Manufacturer: Synthon Hispania, S.L. (production of finished dosage form, primary and secondary packaging, batch control, batch release)
-
The drug is used for the symptomatic treatment of urinary urgency, urinary incontinence, and other symptoms characteristic of overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 3.77 mg ATC: G04BD08
Manufacturer: Pharmaceutical Plant "Polpharma" S.A. (full production cycle)
-
The drug is used for the symptomatic treatment of urinary frequency, urinary incontinence, and other symptoms characteristic of overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 7.54 mg ATC: G04BD08
Manufacturer: Pharmaceutical Plant "Polpharma" S.A. (full production cycle)
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 3.8 mg ATC: G04BD08
-
The drug is used for the symptomatic treatment of urinary urgency, urinary incontinence, and other symptoms characteristic of overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 7.5 mg ATC: G04BD08
-
The drug is used for the symptomatic treatment of urinary frequency, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 3.8 mg ATC: G04BD08
Manufacturer: Saneca Pharmaceuticals JSC
-
The drug is used for the symptomatic treatment of urinary frequency, urinary incontinence, and urgent need to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 7.5 mg ATC: G04BD08
Manufacturer: Saneca Pharmaceuticals JSC
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, as well as sudden (urgent) urges to urinate that occur in overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 3.8 mg ATC: G04BD08
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 7.5 mg ATC: G04BD08
-
The drug is used for the symptomatic treatment of urinary frequency, urinary incontinence, and strong urges to urinate that occur in overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 10 mg ATC: G04BD08
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 5 mg ATC: G04BD08
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 5 mg ATC: G04BD08
Manufacturer: Anorra Pharma Private Limited
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 10 mg ATC: G04BD08
Manufacturer: Anorra Pharma Private Limited
-
The drug is prescribed to men to treat bladder storage symptoms (frequent or urgent urges to urinate) and bladder emptying symptoms (difficulty with voiding) associated with benign prostatic hyperplasia, if other treatment methods have not helped.
Form: tablets, modified release
Active substance Dosage solifenacin 4.5 mg tamsulosin 0.37 mg ATC: G04CA53
Manufacturer: Adamed Pharma S.A.
-
The drug is used for the symptomatic treatment of urinary frequency, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 5 mg ATC: G04BD08
Manufacturer: Delpharm Meppel B.V.
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 10 mg ATC: G04BD08
Manufacturer: Delpharm Meppel B.V.
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 5 mg ATC: G04BD08
Manufacturer: Medocemi LTD (Factory AZ) (primary and secondary packaging)
-
The drug is used for the symptomatic treatment of urinary frequency, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Form: tablets, film-coated
Active substance Dosage solifenacin 10 mg ATC: G04BD08
Manufacturer: Medocemi LTD (Factory AZ) (primary and secondary packaging)
-
The drug is used to treat men with benign prostatic hyperplasia who have not responded to monotherapy. It helps with bladder storage symptoms (frequent urination, urgency) and bladder emptying symptoms (urinary flow obstruction).
Form: tablets, modified release
Active substance Dosage solifenacin 4.5 mg tamsulosin 0.37 mg ATC: G04CA53
Manufacturer: Avara Pharmaceuticals Technologies Inc. (manufacturing bulk)